Monocyte chemotactic protein-1-induced protein-1 (MCPIP1) is a novel multifunctional modulator of inflammatory reactions

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1823, Issue 10, 2012, Pages 1905-1913

  Jura, Jolanta ^a   Skalniak, Lukasz ^a   Koj, Aleksander ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Deubiquitinase; MRNA stability and decay; NF kappaB signaling cascade; Proinflammatory cytokines; RNase; Ubiquitin binding domains

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLAMMASOME; INTERLEUKIN 1; LIPOPOLYSACCHARIDE; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN INDUCED PROTEIN 1; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UNCLASSIFIED DRUG;

ADIPOGENESIS; ANGIOGENESIS; BONE MARROW; CELL DIFFERENTIATION; DOWN REGULATION; GROWTH RETARDATION; HEART; HUMAN; INFLAMMATION; LYMPHADENOPATHY; NONHUMAN; PLACENTA; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; SPLEEN; SPLENOMEGALY; ZINC FINGER MOTIF;

ANIMALS; HUMANS; INFLAMMATION; MODELS, BIOLOGICAL; NF-KAPPA B; PROTEOLYSIS; RIBONUCLEASES; RNA STABILITY;

MURINAE; MUS;

EID: 84864818117     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2012.06.029     Document Type: Review

References (101)

1. Kushner I. The phenomenon of the acute phase response. Ann. N. Y. Acad. Sci. 1982, 389:39-48.
2. Akira S., Uematsu S., Takeuchi O. Pathogen recognition and innate immunity. Cell 2006, 124:783-801.
3. Dinarello C.A. Immunological and inflammatory functions of the interleukin-1 family. Annu. Rev. Immunol. 2009, 27:519-550.
4. Koj A. From the obscure and mysterious acute phase response to toll-like receptors and the cytokine network. Curr. Immunol. Rev. 2008, 4:199-214. (16).
5. Medzhitov R. Inflammation 2010: new adventures of an old flame. Cell 2010, 140:771-776.
6. Dinarello C.A. Anti-inflammatory agents: present and future. Cell 2010, 140:935-950.
7. Medzhitov R., Preston-Hurlburt P., Janeway C.A. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997, 388:394-397.
8. Chen K., Huang J., Gong W., Iribarren P., Dunlop N.M., Wang J.M. Toll-like receptors in inflammation, infection and cancer. Int. Immunopharmacol. 2007, 7:1271-1285.
9. Takeuchi O., Akira S. Pattern recognition receptors and inflammation. Cell 2010, 140:805-820.
10. Martinon F., Mayor A., Tschopp J. The inflammasomes: guardians of the body. Annu. Rev. Immunol. 2009, 27:229-265.
11. Church L.D., Cook G.P., McDermott M.F. Primer: inflammasomes and interleukin 1beta in inflammatory disorders. Nat. Clin. Pract. Rheumatol. 2008, 4:34-42.
12. Rock K.L., Latz E., Ontiveros F., Kono H. The sterile inflammatory response. Annu. Rev. Immunol. 2010, 28:321-342.
13. Koj A., Guzdek A. Modified proteins as possible signals in the acute phase response. Ann. N. Y. Acad. Sci. 1995, 762:108-118. (discussion 118-9).
14. Schroder K., Tschopp J. The inflammasomes. Cell 2010, 140:821-832.
15. Shapiro L., Dinarello C.A. Hyperosmotic stress as a stimulant for proinflammatory cytokine production. Exp. Cell Res. 1997, 231:354-362.
16. Bode J.G., Gatsios P., Ludwig S., Rapp U.R., Haussinger D., Heinrich P.C., Graeve L. The mitogen-activated protein (MAP) kinase p38 and its upstream activator MAP kinase kinase 6 are involved in the activation of signal transducer and activator of transcription by hyperosmolarity. J. Biol. Chem. 1999, 274:30222-30227.
17. Wenger R.H., Rolfs A., Marti H.H., Bauer C., Gassmann M. Hypoxia, a novel inducer of acute phase gene expression in a human hepatoma cell line. J. Biol. Chem. 1995, 270:27865-27870.
18. Bogdan C., Rollinghoff M., Diefenbach A. Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity. Curr. Opin. Immunol. 2000, 12:64-76.
19. Feldmeyer L., Keller M., Niklaus G., Hohl D., Werner S., Beer H.D. The inflammasome mediates UVB-induced activation and secretion of interleukin-1beta by keratinocytes. Curr. Biol. 2007, 17:1140-1145.
20. Ogura Y., Sutterwala F.S., Flavell R.A. The inflammasome: first line of the immune response to cell stress. Cell 2006, 126:659-662.
21. Lister M.F., Sharkey J., Sawatzky D.A., Hodgkiss J.P., Davidson D.J., Rossi A.G., Finlayson K. The role of the purinergic P2X7 receptor in inflammation. J. Inflamm. (Lond.) 2007, 4:5.
22. Gregory S.M., Davis B.K., West J.A., Taxman D.J., Matsuzawa S., Reed J.C., Ting J.P., Damania B. Discovery of a viral NLR homolog that inhibits the inflammasome. Science 2011, 331:330-334.
23. Chang L., Karin M. Mammalian MAP kinase signalling cascades. Nature 2001, 410:37-40.
24. Kyriakis J.M., Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol. Rev. 2001, 81:807-869.
25. Clark A.R., Dean J.L., Saklatvala J. Post-transcriptional regulation of gene expression by mitogen-activated protein kinase p38. FEBS Lett. 2003, 546:37-44.
26. Cuenda A., Rousseau S. p38 MAP-kinases pathway regulation, function and role in human diseases. Biochim. Biophys. Acta 2007, 1773:1358-1375.
27. Whitmarsh A.J. A central role for p38 MAPK in the early transcriptional response to stress. BMC Biol. 2010, 8:47.
28. Bonizzi G., Piette J., Merville M.P., Bours V. Cell type-specific role for reactive oxygen species in nuclear factor-kappaB activation by interleukin-1. Biochem. Pharmacol. 2000, 59:7-11.
29. Jura J., Wegrzyn P., Korostynski M., Guzik K., Oczko-Wojciechowska M., Jarzab M., Kowalska M., Piechota M., Przewlocki R., Koj A. Identification of interleukin-1 and interleukin-6-responsive genes in human monocyte-derived macrophages using microarrays. Biochim. Biophys. Acta 2008, 1779:383-389.
30. Matsushita K., Takeuchi O., Standley D.M., Kumagai Y., Kawagoe T., Miyake T., Satoh T., Kato H., Tsujimura T., Nakamura H., Akira S. Zc3h12a is an RNase essential for controlling immune responses by regulating mRNA decay. Nature 2009, 458:1185-1190.
31. Anderson P. Post-transcriptional regulons coordinate the initiation and resolution of inflammation. Nat. Rev. Immunol. 2010, 10:24-35.
32. Koj A. Initiation of acute phase response and synthesis of cytokines. Biochim. Biophys. Acta 1996, 1317:84-94.
33. Hoffmann A., Baltimore D. Circuitry of nuclear factor kappaB signaling. Immunol. Rev. 2006, 210:171-186.
34. Poli V. The role of C/EBP isoforms in the control of inflammatory and native immunity functions. J. Biol. Chem. 1998, 273:29279-29282.
35. Hattori M., Tugores A., Westwick J.K., Veloz L., Leffert H.L., Karin M., Brenner D.A. Activation of activating protein 1 during hepatic acute phase response. Am. J. Physiol. 1993, 264:G95-G103.
36. Liang J., Saad Y., Lei T., Wang J., Qi D., Yang Q., Kolattukudy P.E., Fu M. MCP-induced protein 1 deubiquitinates TRAF proteins and negatively regulates JNK and NF-kappaB signaling. J. Exp. Med. 2010, 207:2959-2973.
37. Baumann H. STAT activation in the acute phase response. Activation and Biology 2003, 465-491. Kluwer Academic Publishers, Dordrecht-Boston-London. P.B. Sehgal, D.E. Levy, T. Hirano (Eds.).
38. Lai C.F., Ripperger J., Morella K.K., Wang Y., Gearing D.P., Horseman N.D., Campos S.P., Fey G.H., Baumann H. STAT3 and STAT5B are targets of two different signal pathways activated by hematopoietin receptors and control transcription via separate cytokine response elements. J. Biol. Chem. 1995, 270:23254-23257.
39. Dendorfer U., Oettgen P., Libermann T.A. Multiple regulatory elements in the interleukin-6 gene mediate induction by prostaglandins, cyclic AMP, and lipopolysaccharide. Mol. Cell. Biol. 1994, 14:4443-4454.
40. Kasza A., Wyrzykowska P., Horwacik I., Tymoszuk P., Mizgalska D., Palmer K., Rokita H., Sharrocks A.D., Jura J. Transcription factors Elk-1 and SRF are engaged in IL1-dependent regulation of ZC3H12A expression. BMC Mol. Biol. 2010, 11:14.
41. Gerhauser I., Alldinger S., Baumgartner W. Ets-1 represents a pivotal transcription factor for viral clearance, inflammation, and demyelination in a mouse model of multiple sclerosis. J. Neuroimmunol. 2007, 188:86-94.
42. Ray A., LaForge K.S., Sehgal P.B. On the mechanism for efficient repression of the interleukin-6 promoter by glucocorticoids: enhancer, TATA box, and RNA start site (Inr motif) occlusion. Mol. Cell. Biol. 1990, 10:5736-5746.
43. Chen C.Y., Shyu A.B. AU-rich elements: characterization and importance in mRNA degradation. Trends Biochem. Sci. 1995, 20:465-470.
44. Tudor C., Marchese F.P., Hitti E., Aubareda A., Rawlinson L., Gaestel M., Blackshear P.J., Clark A.R., Saklatvala J., Dean J.L. The p38 MAPK pathway inhibits tristetraprolin-directed decay of interleukin-10 and pro-inflammatory mediator mRNAs in murine macrophages. FEBS Lett. 2009, 583:1933-1938.
45. Srikantan S., Gorospe M. Regulation of mRNA turnover by cellular stress. Handbook of Cell Signaling 2008, 2247-2255. Elsevier. R.A. Bradshaw, E.A. Dennis (Eds.).
46. Schott J., Stoecklin G. Networks controlling mRNA decay in the immune system. Wiley Interdiscip. Rev. RNA 2010, 1:432-456.
47. Garneau N.L., Wilusz J., Wilusz C.J. The highways and byways of mRNA decay. Nat. Rev. Mol. Cell Biol. 2007, 8:113-126.
48. Lu J.Y., Sadri N., Schneider R.J. Endotoxic shock in AUF1 knockout mice mediated by failure to degrade proinflammatory cytokine mRNAs. Genes Dev. 2006, 20:3174-3184.
49. Lai W.S., Blackshear P.J. Interactions of CCCH zinc finger proteins with mRNA: tristetraprolin-mediated AU-rich element-dependent mRNA degradation can occur in the absence of a poly(A) tail. J. Biol. Chem. 2001, 276:23144-23154.
50. Stoecklin G., Stubbs T., Kedersha N., Wax S., Rigby W.F., Blackwell T.K., Anderson P. MK2-induced tristetraprolin:14-3-3 complexes prevent stress granule association and ARE-mRNA decay. EMBO J. 2004, 23:1313-1324.
51. Dean J.L., Sully G., Clark A.R., Saklatvala J. The involvement of AU-rich element-binding proteins in p38 mitogen-activated protein kinase pathway-mediated mRNA stabilisation. Cell. Signal. 2004, 16:1113-1121.
52. Tchen C.R., Brook M., Saklatvala J., Clark A.R. The stability of tristetraprolin mRNA is regulated by mitogen-activated protein kinase p38 and by tristetraprolin itself. J. Biol. Chem. 2004, 279:32393-32400.
53. Deleault K.M., Skinner S.J., Brooks S.A. Tristetraprolin regulates TNF TNF-alpha mRNA stability via a proteasome dependent mechanism involving the combined action of the ERK and p38 pathways. Mol. Immunol. 2008, 45:13-24.
54. Mizgalska D., Wegrzyn P., Murzyn K., Kasza A., Koj A., Jura J., Jarzab B., Jura J. Interleukin-1-inducible MCPIP protein has structural and functional properties of RNase and participates in degradation of IL-1beta mRNA. FEBS J. 2009, 276:7386-7399.
55. Iwasaki H., Takeuchi O., Teraguchi S., Matsushita K., Uehata T., Kuniyoshi K., Satoh T., Saitoh T., Matsushita M., Standley D.M., Akira S. The IkappaB kinase complex regulates the stability of cytokine-encoding mRNA induced by TLR-IL-1R by controlling degradation of regnase-1. Nat. Immunol. 2011, 12:1167-1175.
56. Suzuki H.I., Arase M., Matsuyama H., Choi Y.L., Ueno T., Mano H., Sugimoto K., Miyazono K. MCPIP1 ribonuclease antagonizes dicer and terminates microRNA biogenesis through precursor microRNA degradation. Mol. Cell 2011, 44:424-436.
57. Cok S.J., Acton S.J., Morrison A.R. The proximal region of the 3'-untranslated region of cyclooxygenase-2 is recognized by a multimeric protein complex containing HuR, TIA-1, TIAR, and the heterogeneous nuclear ribonucleoprotein U. J. Biol. Chem. 2003, 278:36157-36162.
58. Gherzi R., Trabucchi M., Ponassi M., Ruggiero T., Corte G., Moroni C., Chen C.Y., Khabar K.S., Andersen J.S., Briata P. The RNA-binding protein KSRP promotes decay of beta-catenin mRNA and is inactivated by PI3K-AKT signaling. PLoS Biol. 2006, 5:e5.
59. Valencia-Sanchez M.A., Liu J., Hannon G.J., Parker R. Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev. 2006, 20:515-524.
60. Wu L., Belasco J.G. Examining the influence of microRNAs on translation efficiency and on mRNA deadenylation and decay. Methods Enzymol. 2008, 449:373-393.
61. Chendrimada T.P., Finn K.J., Ji X., Baillat D., Gregory R.I., Liebhaber S.A., Pasquinelli A.E., Shiekhattar R. MicroRNA silencing through RISC recruitment of eIF6. Nature 2007, 447:823-828.
62. Fan Y., Yu Y., Shi Y., Sun W., Xie M., Ge N., Mao R., Chang A., Xu G., Schneider M.D., Zhang H., Fu S., Qin J., Yang J. Lysine 63-linked polyubiquitination of TAK1 at lysine 158 is required for tumor necrosis factor alpha- and interleukin-1beta-induced IKK/NF-kappaB and JNK/AP-1 activation. J. Biol. Chem. 2010, 285:5347-5360.
63. Skaug B., Jiang X., Chen Z.J. The role of ubiquitin in NF-kappaB regulatory pathways. Annu. Rev. Biochem. 2009, 78:769-796.
64. Ordureau A., Smith H., Windheim M., Peggie M., Carrick E., Morrice N., Cohen P. The IRAK-catalysed activation of the E3 ligase function of Pellino isoforms induces the Lys63-linked polyubiquitination of IRAK1. Biochem. J. 2008, 409:43-52.
65. Pop C., Salvesen G.S. Human caspases: activation, specificity, and regulation. J. Biol. Chem. 2009, 284:21777-21781.
66. Koj A. Termination of acute-phase response: role of some cytokines and anti-inflammatory drugs. Gen. Pharmacol. 1998, 31:9-18.
67. Liu S.F., Malik A.B. NF-kappa B activation as a pathological mechanism of septic shock and inflammation. Am. J. Physiol. Lung Cell. Mol. Physiol. 2006, 290:L622-L645.
68. Rihl M., Barthel C., Klos A., Schmidt R.E., Tak P.P., Zeidler H., Kuipers J.G. Identification of candidate genes for susceptibility to reactive arthritis. Rheumatol. Int. 2009, 29:1519-1522.
69. Duckers W., Tacke F., Trautwein C., Koch A. Adipocytokines in severe sepsis and septic shock. Acute Phase Proteins-Regulation and Functions of Acute Phase Proteins 2011, 211-228. InTech. F. Veas (Ed.).
70. Evans P.C. Regulation of pro-inflammatory signalling networks by ubiquitin: identification of novel targets for anti-inflammatory drugs. Expert Rev. Mol. Med. 2005, 7:1-19.
71. Moynagh P.N. The NF-kappaB pathway. J. Cell Sci. 2005, 118:4589-4592.
72. Palombella V.J., Rando O.J., Goldberg A.L., Maniatis T. The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B. Cell 1994, 78:773-785.
73. Lin L., DeMartino G.N., Greene W.C. Cotranslational biogenesis of NF-kappaB p50 by the 26S proteasome. Cell 1998, 92:819-828.
74. Pomerantz J.L., Baltimore D. Two pathways to NF-kappaB. Mol. Cell 2002, 10:693-695.
75. Calleros L., Lasa M., Toro M.J., Chiloeches A. Low cell cholesterol levels increase NFkappaB activity through a p38 MAPK-dependent mechanism. Cell. Signal. 2006, 18:2292-2301.
76. Taylor J.A., Bren G.D., Pennington K.N., Trushin S.A., Asin S., Paya C.V. Serine 32 and serine 36 of IkappaBalpha are directly phosphorylated by protein kinase CKII in vitro. J. Mol. Biol. 1999, 290:839-850.
77. Zandi E., Rothwarf D.M., Delhase M., Hayakawa M., Karin M. The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation. Cell 1997, 91:243-252.
78. Dikic I., Wakatsuki S., Walters K.J. Ubiquitin-binding domains-from structures to functions. Nat. Rev. Mol. Cell Biol. 2009, 10:659-671.
79. Verhelst K., Carpentier I., Beyaert R. Regulation of TNF-induced NF-kappaB activation by different cytoplasmic ubiquitination events. Cytokine Growth Factor Rev. 2011, 22:277-286.
80. Zhou L., Azfer A., Niu J., Graham S., Choudhury M., Adamski F.M., Younce C., Binkley P.F., Kolattukudy P.E. Monocyte chemoattractant protein-1 induces a novel transcription factor that causes cardiac myocyte apoptosis and ventricular dysfunction. Circ. Res. 2006, 98:1177-1185.
81. Liang J., Wang J., Azfer A., Song W., Tromp G., Kolattukudy P.E., Fu M. A novel CCCH-zinc finger protein family regulates proinflammatory activation of macrophages. J. Biol. Chem. 2008, 283:6337-6346.
82. Gavrilin M.A., Deucher M.F., Boeckman F., Kolattukudy P.E. Monocyte chemotactic protein 1 upregulates IL-1beta expression in human monocytes. Biochem. Biophys. Res. Commun. 2000, 277:37-42.
83. Becker L.C. Yin and yang of MCP-1. Circ. Res. 2005, 96:812-814.
84. Niu J., Azfer A., Zhelyabovska O., Fatma S., Kolattukudy P.E. Monocyte chemotactic protein (MCP)-1 promotes angiogenesis via a novel transcription factor, MCP-1-induced protein (MCPIP). J. Biol. Chem. 2008, 283:14542-14551.
85. Sparna T., Retey J., Schmich K., Albrecht U., Naumann K., Gretz N., Fischer H.P., Bode J.G., Merfort I. Genome-wide comparison between IL-17 and combined TNF-alpha/IL-17 induced genes in primary murine hepatocytes. BMC Genomics 2010, 11:226.
86. Skalniak L., Mizgalska D., Zarebski A., Wyrzykowska P., Koj A., Jura J. Regulatory feedback loop between NF-kappaB and MCP-1-induced protein 1 RNase. FEBS J. 2009, 276:5892-5905.
87. Younce C.W., Kolattukudy P.E. MCP-1 causes cardiomyoblast death via autophagy resulting from ER stress caused by oxidative stress generated by inducing a novel zinc-finger protein, MCPIP. Biochem. J. 2010, 426:43-53.
88. Kolattukudy P.E., Niu J. Inflammation, endoplasmic reticulum stress, autophagy, and the monocyte chemoattractant protein-1/CCR2 pathway. Circ. Res. 2012, 110:174-189.
89. Younce C.W., Azfer A., Kolattukudy P.E. MCP-1 (monocyte chemotactic protein-1)-induced protein, a recently identified zinc finger protein, induces adipogenesis in 3T3-L1 pre-adipocytes without peroxisome proliferator-activated receptor gamma. J. Biol. Chem. 2009, 284:27620-27628.
90. Vrotsos E.G., Kolattukudy P.E., Sugaya K. MCP-1 involvement in glial differentiation of neuroprogenitor cells through APP signaling. Brain Res. Bull. 2009, 79:97-103.
91. Wang K., Niu J., Kim H., Kolattukudy P.E. Osteoclast precursor differentiation by MCPIP via oxidative stress, endoplasmic reticulum stress, and autophagy. J. Mol. Cell Biol. 2011, 3:360-368.
92. Xu J., Peng W., Sun Y., Wang X., Xu Y., Li X., Gao G., Rao Z. Structural study of MCPIP1 N-terminal conserved domain reveals a PIN-like RNase. Nucleic Acids Res. 2012.
93. Paschoud S., Dogar A.M., Kuntz C., Grisoni-Neupert B., Richman L., Kuhn L.C. Destabilization of interleukin-6 mRNA requires a putative RNA stem-loop structure, an AU-rich element, and the RNA-binding protein AUF1. Mol. Cell. Biol. 2006, 26:8228-8241.
94. Sun S.C. Deubiquitylation and regulation of the immune response. Nat. Rev. Immunol. 2008, 8:501-511.
95. Cifuentes R.A., Cruz-Tapias P., Rojas-Villarraga A., Anaya J.M. ZC3H12A (MCPIP1): molecular characteristics and clinical implications. Clin. Chim. Acta 2010, 411:1862-1868.
96. Qi Y., Liang J., She Z.G., Cai Y., Wang J., Lei T., Stallcup W.B., Fu M. MCP-induced protein 1 suppresses TNFalpha-induced VCAM-1 expression in human endothelial cells. FEBS Lett. 2010, 584:3065-3072.
97. Niu J., Wang K., Graham S., Azfer A., Kolattukudy P.E. MCP-1-induced protein attenuates endotoxin-induced myocardial dysfunction by suppressing cardiac NF-kappaB activation via inhibition of IkappaB kinase activation. J. Mol. Cell. Cardiol. 2011, 51:177-186.
98. Qi D., Huang S., Miao R., She Z.G., Quinn T., Chang Y., Liu J., Fan D., Chen Y.E., Fu M. Monocyte chemotactic protein-induced protein 1 (MCPIP1) suppresses stress granule formation and determines apoptosis under stress. J. Biol. Chem. 2011, 286:41692-41700.
99. Koga T., Yamasaki S., Migita K., Kita J., Okada A., Kawashiri S., Iwamoto N., Tamai M., Arima K., Origuchi T., Nakamura H., Osaki M., Tsurumoto T., Shindo H., Eguchi K., Kawakami A. Post-transcriptional regulation of IL-6 production by Zc3h12a in fibroblast-like synovial cells. Clin. Exp. Rheumatol. 2011, 29:906-912.
100. Liang J., Wang J., Saad Y., Warble L., Becerra E., Kolattukudy P.E. Participation of MCP-induced protein 1 in lipopolysaccharide preconditioning-induced ischemic stroke tolerance by regulating the expression of proinflammatory cytokines. J. Neuroinflammation 2011, 8:182.
101. Jura J., Koj A. Regulatory mechanisms controlling inflammation and synthesis of acute phase proteins. Acute Phase Proteins-Regulation and Functions of Acute Phase Proteins 2011, 61-84. InTech. F. Veas (Ed.).